Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas

Neuro Oncol. 2017 Jul 1;19(7):1008-1010. doi: 10.1093/neuonc/nox042.
No abstract available

Keywords: IDH; TERT promoter; gliomas; primary; recurrent.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Astrocytoma / classification
  • Astrocytoma / genetics
  • Astrocytoma / pathology
  • Brain Neoplasms / classification
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / pathology
  • Chromosomes, Human, Pair 1 / genetics
  • Chromosomes, Human, Pair 19 / genetics
  • Disease Progression
  • Female
  • Gene Deletion
  • Glioblastoma / genetics
  • Glioma / classification
  • Glioma / genetics*
  • Glioma / pathology
  • Humans
  • Isocitrate Dehydrogenase / genetics*
  • Male
  • Middle Aged
  • Mutation
  • Neoplasm Grading
  • Neoplasm Recurrence, Local / genetics*
  • Oligodendroglioma / classification
  • Oligodendroglioma / genetics
  • Oligodendroglioma / pathology
  • Promoter Regions, Genetic / genetics
  • Telomerase / genetics*
  • Young Adult

Substances

  • IDH2 protein, human
  • Isocitrate Dehydrogenase
  • IDH1 protein, human
  • TERT protein, human
  • Telomerase